Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

(2012) Ricardo P Garay et al.   Expert Opinion on Drug Delivery

A double antigen bridging immunogenicity ELISA for the detection of antibodies to polyethylene glycol polymers

(2011) Yijuan Liu et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation

(2010) J. D. Belsey et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Delivery of Therapeutic Proteins

(2010) Dipak S. Pisal et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

(2009) Yu Cheng Tang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

(2009) Tsutomu Ishihara et al.   PHARMACEUTICAL RESEARCH

The Impact of PEGylation on Biological Therapies

(2008) Francesco M Veronese et al.   BIODRUGS

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

(2007) Merry R. Sherman et al.   ADVANCED DRUG DELIVERY REVIEWS

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

(2007) Tatsuhiro Ishida et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS